Engagement of chymase-positive mast cells in myocardial damage associated with COVID-19
Frontiers in Cardiovascular Medicine · 07.05.2026 · 13
DOI: 10.3389/fcvm.2026.1816510 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 07.05.2026. Verfasst von Andrey V Budnevsky und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Faculty Therapy, Burdenko Voronezh State Medical University, Voronezh, Russia. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Acute myocardial injury is a frequent and severe complication of COVID-19, contributing to increased mortality. This study investigates the role of chymase-positive mast cells (MCs) in myocardial damage among patients who died from severe or critical COVID-19.
Methods
Cardiac tissue samples from 60 deceased patients were analyzed histologically and immunohistochemically to assess MC density, degranulation status, and associated fibrotic remodeling. Clinical and laboratory parameters, including troponin I levels and inflammatory markers were obtained during hospitalization period.
Results
The findings revealed a low overall density of cardiac MCs, with a predominance of degranulated chymase-positive cells. These MCs were significantly correlated with indicators of severe COVID-19 progression, such as neutrophilic leukocytosis, elevated band neutrophils, monocytosis, and increased erythrocyte sedimentation rate. A strong association was also observed between chymase-positive MCs and elevated troponin I levels, the association between troponin I and degranulating chymase-positive MC density remained statistically significant after multivariable adjustment, supporting an independent link to myocardial injury. Additionally, increased MC presence coincided with extensive interstitial and perivascular fibrosis, marked by a predominance of type III collagen.
Conclusions
These results support the hypothesis that chymase-positive MCs contribute to myocardial inflammation and fibrosis in the context of COVID-19. Understanding their role may open avenues for targeted therapies aimed at mitigating cardiac complications in future coronavirus-related diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Faculty Therapy, Burdenko Voronezh State Medical University, Voronezh, Russia.
- Department of Pulmonology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
- Department of Histology, Burdenko Voronezh State Medical University, Voronezh, Russia.
- Scientific Research Institute of Experimental Biology and Medicine, Burdenko Voronezh State Medical University, Voronezh, Russia.
- Department of Pathological Anatomy, Burdenko Voronezh State Medical University, Voronezh, Russia.
- Voronezh Regional Pathoanatomical Bureau, Voronezh, Russia.
Zitieren
APA
Budnevsky, A. V., Avdeev, S. N., Arkhipova, E. D., Kosanovic, D., Shishkina, V. V., Chernik, T. A., Ovsyannikov, E. S., Perveeva, I. M., Filin, A. A., Tokmachev, R. E., Pertsev, A. V., Ivanova, E. E., Samoylenko, T. V., & Antakova, L. N. (2026). Engagement of chymase-positive mast cells in myocardial damage associated with COVID-19. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1816510
Vancouver
Budnevsky AV, Avdeev SN, Arkhipova ED, Kosanovic D, Shishkina VV, Chernik TA, et al. Engagement of chymase-positive mast cells in myocardial damage associated with COVID-19. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1816510
BibTeX
@article{Budnevsky2026,
author = {Budnevsky, Andrey V and Avdeev, Sergey N and Arkhipova, Ekaterina D and Kosanovic, Djuro and Shishkina, Viktoria V and Chernik, Tatiana A and Ovsyannikov, Evgeniy S and Perveeva, Inna M and Filin, Andrey A and Tokmachev, Roman E and Pertsev, Alexander V and Ivanova, Elena E and Samoylenko, Tatiana V and Antakova, Lyubov N},
title = {Engagement of chymase-positive mast cells in myocardial damage associated with COVID-19},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1816510}
}
EUVIMED